Journals / Turkish Journal of Pediatrics / 2016 / Cilt: 58 - Sayı: 1

Microorganisms isolated from cultures and infection focus and antibiotic treatments in febrile neutropenic children from Şanlıurfa, Turkey

Pages
47–53
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The overall response rates were 70.5%, 86.9%, and 66.6% of first line, second line and third line therapies, respectively.The spectrum of isolates among febrile neutropenic children in our hematology clinic appears to be gram positive pathogens which are the most common agents.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Özdemir ZC, Koç A, Ayçiçek A.
📊
Key Findings & Data:Turk J Pediatr 2016; 58: 47-53.Chemotherapy induced febrile neutropenia predisposes patients to life threatening infections.
💡
Conclusion & Impact:The overall response rates were 70.5%, 86.9%, and 66.6% of first line, second line and third line therapies, respectively.The spectrum of isolates among febrile neutropenic children in our hematology clinic appears to be gram positive pathogens which are the most common agents.
🔬Design:Review & Systematic Survey
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Özdemir ZC, Koç A, Ayçiçek A. Microorganisms isolated from cultures and infection focus and antibiotic treatments in febrile neutropenic children from Şanlıurfa, Turkey. Turk J Pediatr 2016; 58: 47-53.Chemotherapy induced febrile neutropenia predisposes patients to life threatening infections. We aimed to determine the causative microorganisms, infection focus and antibiotic treatment success in febrile neutropenic children with leukemia. A total of 136 febrile neutropenic episodes in 48 leukemic children were reviewed retrospectively from records. Among 136 febrile neutropenic episodes, 68 (50%) episodes were microbiologically documented. Methicillin sensitive coagulase (-) Staphylococcus aureus were the most common isolates from hemoculture (20.5%). The most frequently documented infection focus was mucositis (31.9%). Ceftazidime plus amikacin was the most commonly used antimicrobial treatment for the empirical therapy (52.9%). The overall response rates were 70.5%, 86.9%, and 66.6% of first line, second line and third line therapies, respectively.The spectrum of isolates among febrile neutropenic children in our hematology clinic appears to be gram positive pathogens which are the most common agents. Therefore the, documentation of the flora in each unit could help to decide appropriate empirical therapy which is life saving

🔖

Cite This Article

AYÇİÇEK, A., ÖZDEMİR, Z. C., KOÇ, A. (2022). Microorganisms isolated from cultures and infection focus and antibiotic treatments in febrile neutropenic children from Şanlıurfa, Turkey. Turkish Journal of Pediatrics, Cilt: 58 - Sayı: 1, 47–53. https://ajindex.com/articles/613197

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Hurtado IC, Sánchez DP, Espinal DA, Garcés C. Clinical and laboratory evolution of the febrile neutropenia episodes in pediatric patients hospitalized in a Colombian hospital in 2007-2009. Rev Chilena Infectol 2012; 29: 672-676
  2. Paul M, Yahav D, Fraser A, Leibovici L. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 2006; 57: 176-189
  3. Laoprasopwattana K, Pruekprasert P, Laosombat V, Wongchanchailert M. Clinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides. Pediatric Hematol Oncol 2007; 24: 595-606
  4. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis 1999; 29: 490-494
  5. Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Grout (IATCG) of the European Organization for Research and Treatment for Cancer (EORTC). Br J Haematol 1997; 99: 580-588
  6. Gabay M, Tanzı M. Guidelines for the Managament of Febrile Neutropenia. Clinical Oncology News Special Edition 2010; 1: 115-122
  7. Jin J, Lee YM, Ding Y, et al. Prospective audit of febril neutropenia management at a Tertiary University hospital in Singapore. Ann Acad Med Singapore 2010; 39: 453-459
  8. Paul M, Gafter-Gvili A, Leibovici L, et al. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004. Isr Med Assoc J 2007; 9: 424-429
  9. Klaassen IL, de Haas V, van Wijk JA, Kaspers GJ, Bijlsma M, Bökenkamp A. Pyuria is absent during urinary tract infections in neutropenic patients. Pediatr Blood Cancer 2011; 56: 868-870
  10. Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur A. Etiology and Clinical Course of Febrile Neutropenia in Children with Cancer. Pediatr Hematol Oncol 2009; 31: 623-629
  11. Güneş D, Mutafoğlu K, Çetinkaya H, Arslan H, Çakır D, Olgun N. Febrile neutropenic episodes in children with lymphoma and malignant solid tumors. J Pediatr Inf 2010; 4: 1-8
  12. Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis 2005; 40(Suppl 4): 240-245
  13. Santolaya ME, Alvarez AM, Avilés CL, et al. Admission clinical and laboratory factors associate